Back to search

Article

Effective allogeneic natural killer cell therapy for pancreatic adenocarcinoma avails conserved activating receptors and evades HLA I-driven inhibition

2025-09-21

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Background</h4> At diagnosis, ∼80% of pancreatic ductal adenocarcinomas (PDAC) have metastasized. Relapse is thus common even among patients that undergo surgical resection, the only curative option. PDAC progresses rapidly, and existing immunotherapies have been ineffective. We hypothesized that natural killer (NK) cell immunotherapies could be effective against PDAC because they recognize...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
bfb0f1b6-fe13-50d9-a847-f610b5fb69b3
DOI
10.1101/2025.09.21.677560
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Effective allogeneic natural killer cell therapy for pancreatic adenocarcinoma avails conserved activating receptors and evades HLA I-driven inhibitionDOI 10.1101/2025.09.21.677560
Select a neighboring publication to make it the new centre.